Skip to content

Clinical Evaluation of Navigated 3D Ultrasound Multicentre Study

Clinical Evaluation of Navigated 3D Ultrasound Multicentre Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00233350
Enrollment
142
Registered
2005-10-05
Start date
2007-01-31
Completion date
2009-12-31
Last updated
2015-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Neoplasms

Keywords

Neuronavigation, Ultrasound, Brain tumour surgery, Biopsy, Histopathology, Intraoperative imaging, 3D ultrasound imaging

Brief summary

3D ultrasound is a new modality used in image guided neurosurgery. a multicentre study is started for the evaluation of this tool as a means for achieving total resection of brain tumors at greater safety.

Detailed description

The degree of resection as judged by the surgeon is recorded at the end of surgery for each patient, and then compared with the postoperative MRI. Neurological status before and after surgery, QOL before surgery and at follow-up as well as survival is recorded.

Interventions

DEVICEuse of navigated 3D ultrasound during surgery

Sponsors

St. Olavs Hospital
CollaboratorOTHER
Norwegian University of Science and Technology
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Supratentorial glioma

Exclusion criteria

* Not willing to participate in study

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026